Healthleap, a clinical AI company developing automated inpatient screening technology, has raised $38 million in combined seed and Series A financing to expand its platform and address underdiagnosed conditions in hospital settings. The funding comprises an $8 million seed round and a $30 million Series A round.
Founded in 2022 by siblings Josiah and Jemima Meyer, Healthleap has developed an electronic health record (EHR)-integrated platform that continuously analyzes patient information to identify conditions that traditional screening methods may overlook.
The company initially focuses on disease-related malnutrition, a condition affecting up to 50% of hospitalized patients considered clinically at risk, while fewer than 9% receive a formal diagnosis. Conventional hospital screening typically relies on questionnaires administered at admission, potentially overlooking critically ill, sedated or otherwise unresponsive patients.
Healthleap's platform addresses these limitations by analyzing complete patient records every morning, incorporating clinical notes, laboratory results, vital signs, medications and medical histories. Its algorithms prioritize patients requiring further evaluation and integrate findings into existing clinical workflows.
Reported deployments have demonstrated clinical and financial outcomes. At one Penn Medicine hospital, the platform generated an estimated $23.8 million in annual financial benefits through additional reimbursement and reduced lengths of stay.
Across enterprise health system implementations, Healthleap reported a 39% increase in identified and treated malnutrition cases, alongside $11 million in incremental reimbursement within one network. Accurate documentation of severe malnutrition can qualify hospitals for approximately $11,000 in additional reimbursement per eligible encounter.
The company is extending its screening technology beyond malnutrition to identify congestive heart failure, pressure ulcers and hospital-acquired infections, including sepsis and catheter-associated infections.
“Finding them now is prevention, and it’s a win for everyone. Patients get treated before they get sicker. Hospitals shorten stays and are paid for the care they deliver. Payers avoid the much larger cost of complications down the road. Our goal is to improve care and save lives by catching these conditions early,” said Josiah Meyer, Healthleap's co-founder and CEO.
The expansion reflects growing interest in AI-enabled clinical surveillance to support earlier intervention and hospital resource management.
Click here for the original news story.
